Later studies have now shown that increased expression of TG2 is found in the lungs of IPF patients and that TG2-KO mice develop significantly reduced bleomycin-induced fibrosis compared to wild-type mice (Olsen et al. 2014). The gene discussed is TGM2; the disease is fibrosis.